< Back to all clusters
[BUSINESS] · United States · 6 sources

started · updated

Elevance Health beats Q3 expectations and raises 2026 outlook

Elevance Health reported third-quarter 2026 financial results that exceeded Wall Street expectations, driven by improved operational efficiency and favorable medical cost trends. The Indianapolis-based insurer posted revenue of $50.44 billion, a 0.7% increase from the previous year, and adjusted earnings per share of $6.99, significantly surpassing the consensus estimate of $4.73.

Net income for the quarter reached $1.36 billion, up 14.8% compared to the same period last year. The company’s Health Benefits segment generated $43.36 billion in revenue. While revenue growth was supported by higher premium yields and CarelonRx product revenue, it was partially offset by lower membership in Medicare Advantage, Medicaid, and Employer Group segments.

Following these results, Elevance Health raised its fiscal 2026 earnings per share guidance to at least $22.00, up from the previous estimate of at least $20.10. The company also increased its adjusted earnings per share outlook to at least $29.00. Looking ahead to 2027, the company expressed confidence in delivering at least 12% growth in adjusted earnings per share.

Entities

CarelonRx · Elevance Health · Gail K. Boudreaux · Indianapolis · NYSE

Claims

What the coverage asserts, and how many sources carry each claim.

  • [○ 1 SOURCE] Adjusted EPS guidance for fiscal 2026 was raised to at least $29.00. www.finanzen.ch
  • [● 3 SOURCES] Adjusted earnings per share for Q3 were $6.99. www.finanzen.ch · www.teleborsa.it
  • [○ 1 SOURCE] Elevance Health served 44,882,000 total medical members at quarter-end.
  • [○ 1 SOURCE] The company raised its fiscal 2026 EPS guidance to at least $22.00. www.finanzen.ch
  • [● 2 SOURCES] Net income for the quarter totaled $1.36 billion. www.finanzen.ch
  • [● 3 SOURCES] Elevance Health reported Q3 2026 revenue of $50.44 billion. www.finanzen.ch · www.teleborsa.it
  • [● 2 SOURCES] The benefit expense ratio was 90.6% for the quarter. www.teleborsa.it
  • [○ 1 SOURCE] The company declared a fourth quarter 2026 dividend of $1.72 per share. www.finanzen.ch